{"id":29087,"date":"2026-08-11T14:06:18","date_gmt":"2026-08-11T21:06:18","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=29087"},"modified":"2026-08-11T14:06:21","modified_gmt":"2026-08-11T21:06:21","slug":"cladribine-mavenclad-usos-funcionamiento-y-efectos-secundarios","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/","title":{"rendered":"Cladribina (Mavenclad): Usos, funcionamiento y efectos secundarios"},"content":{"rendered":"<p class=\"wp-block-paragraph\">La cladribina (nombre comercial: Mavenclad) es un medicamento oral de venta con receta que se utiliza para tratar a adultos con esclerosis m\u00faltiple (EM) recurrente. A diferencia de muchos medicamentos para la EM que requieren tratamiento continuo, Mavenclad se administra en dos ciclos anuales dise\u00f1ados para proporcionar un control duradero de la enfermedad. Debido a sus posibles riesgos, Mavenclad se suele recetar cuando otro tratamiento para la EM no ha sido eficaz o no se tolera. Siga leyendo para obtener m\u00e1s informaci\u00f3n sobre c\u00f3mo funciona Mavenclad, sus usos, la dosis recomendada, los posibles efectos secundarios y el costo.\u00a0<\/p>\n\n\n\n<div  id=\"call-to-action-879953f7f0dcb9cc0312ec6eeffdf269\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia con el copago ahora\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Nota: Este art\u00edculo trata sobre los comprimidos de cladribina, comercializados bajo la marca Mavenclad. La inyecci\u00f3n de cladribina, comercializada bajo la marca Leustatin, se utiliza para tratar el c\u00e1ncer de sangre y m\u00e9dula \u00f3sea.\u00a0<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_87 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Cladribine_Mavenclad_Introduction_and_Uses\" >Introducci\u00f3n y usos de la cladribina (Mavenclad)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Cladribine_Mavenclad_Mechanism_of_Action\" >Mecanismo de acci\u00f3n de la cladribina (Mavenclad)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#How_Effective_Is_Cladribine_Mavenclad\" >\u00bfQu\u00e9 tan efectiva es la cladribina (Mavenclad)?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Important_Cladribine_Mavenclad_Warnings\" >Advertencias importantes sobre la cladribina (Mavenclad)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Risk_of_cancer\" >Riesgo de c\u00e1ncer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Risk_of_harm_to_the_fetus\" >Riesgo de da\u00f1o para el feto<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Before_Taking_Cladribine_Mavenclad_Tablets\" >Antes de tomar comprimidos de cladribina (Mavenclad)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Cladribine_Mavenclad_Dosing\" >Dosificaci\u00f3n de cladribina (Mavenclad)&nbsp;<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#First_treatment_course_year_1\" >Primer ciclo de tratamiento (a\u00f1o 1)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Second_treatment_course_year_2\" >Segundo ciclo de tratamiento (a\u00f1o 2)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Proper_Use\" >Uso adecuado<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Monitoring_During_Treatment\" >Monitorizaci\u00f3n durante el tratamiento<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Cladribine_Mavenclad_Side_Effects\" >Efectos secundarios de la cladribina (Mavenclad)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Common_Side_Effects\" >Efectos secundarios comunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Severe_Side_Effects\" >Efectos secundarios graves<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Cladribine_Mavenclad_Cost\" >Costo de la cladribina (Mavenclad)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/ameripharmaspecialty.com\/es\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#Conclusion\" >Conclusi\u00f3n<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cladribine_Mavenclad_Introduction_and_Uses\"><\/span>Introducci\u00f3n y usos de la cladribina (Mavenclad)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Mavenclad es un medicamento de marca que requiere receta m\u00e9dica. El ingrediente activo es la cladribina, una purina. <a href=\"https:\/\/my.clevelandclinic.org\/health\/drugs\/24790-antimetabolites\">antimetabolito<\/a> que act\u00faa reduciendo ciertas c\u00e9lulas inmunitarias implicadas en la esclerosis m\u00faltiple.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La FDA aprob\u00f3 las tabletas de cladribina en 2019 para el tratamiento de adultos con formas recurrentes de esclerosis m\u00faltiple. Debido a que Mavenclad conlleva riesgos graves, incluyendo un mayor riesgo de c\u00e1ncer y da\u00f1o fetal, generalmente se reserva para personas que no han respondido adecuadamente o no toleran otro tratamiento para la esclerosis m\u00faltiple.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mavenclad est\u00e1 disponible en comprimidos orales de 10 mg. Los comprimidos son redondos y de color blanco a blanquecino.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">No se recomienda el uso de Mavenclad en personas con s\u00edntomas similares a los de la esclerosis m\u00faltiple, pero que no cumplen los criterios para un diagn\u00f3stico de esclerosis m\u00faltiple.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cladribine_Mavenclad_Mechanism_of_Action\"><\/span>Mecanismo de acci\u00f3n de la cladribina (Mavenclad)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">El mecanismo de acci\u00f3n exacto de la cladribina en la esclerosis m\u00faltiple no se comprende completamente. Seg\u00fan el fabricante, act\u00faa reduciendo el n\u00famero de c\u00e9lulas inmunitarias, en particular <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459471\/\">Linfocitos B y T<\/a>, que contribuyen a la inflamaci\u00f3n y al da\u00f1o de la capa protectora de los nervios (mielina). Al reducir el n\u00famero de estas c\u00e9lulas inmunitarias, Mavenclad ayuda a disminuir la actividad de la enfermedad y las reca\u00eddas. Tras el tratamiento, el sistema inmunitario se regenera gradualmente con el tiempo.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Effective_Is_Cladribine_Mavenclad\"><\/span>\u00bfQu\u00e9 tan efectiva es la cladribina (Mavenclad)?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Los estudios cl\u00ednicos han demostrado que Mavenclad puede reducir significativamente la actividad de la enfermedad en personas con formas recurrentes de esclerosis m\u00faltiple. En el ensayo cl\u00ednico de fase 3 CLARITY, las personas tratadas con Mavenclad experimentaron menos reca\u00eddas, menos lesiones cerebrales nuevas detectadas mediante resonancia magn\u00e9tica y una progresi\u00f3n m\u00e1s lenta de la discapacidad que quienes recibieron un placebo. Dado que el tratamiento se administra en ciclos de dos a\u00f1os en lugar de forma continua, muchos pacientes experimentan beneficios duraderos sin necesidad de tomar la medicaci\u00f3n a diario. Su respuesta al tratamiento depender\u00e1 de factores como la gravedad de su enfermedad, las terapias previas y su estado de salud general.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Important_Cladribine_Mavenclad_Warnings\"><\/span>Advertencias importantes sobre la cladribina (Mavenclad)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Este medicamento puede aumentar el riesgo de c\u00e1ncer y da\u00f1ar al feto.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_of_cancer\"><\/span>Riesgo de c\u00e1ncer<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Tomar comprimidos de cladribina puede aumentar el riesgo de desarrollar c\u00e1ncer. Hable con su m\u00e9dico sobre este riesgo. Preg\u00fantele si necesita realizarse pruebas de detecci\u00f3n de c\u00e1ncer.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_of_harm_to_the_fetus\"><\/span>Riesgo de da\u00f1o para el feto<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Si usted es mujer y puede quedar embarazada, su m\u00e9dico le solicitar\u00e1 una prueba de embarazo antes de cada ciclo de tratamiento.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tomar comprimidos de cladribina durante el embarazo puede causar defectos cong\u00e9nitos o la p\u00e9rdida del embarazo. No tome este medicamento si est\u00e1 embarazada o planea quedar embarazada. Si queda embarazada durante el tratamiento con cladribina, suspenda el tratamiento y llame a su m\u00e9dico de inmediato.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los anticonceptivos hormonales, incluidas las p\u00edldoras anticonceptivas, pueden no prevenir completamente el embarazo cuando se usan junto con las tabletas de cladribina. Por lo tanto, utilice otro m\u00e9todo anticonceptivo junto con los anticonceptivos hormonales durante el tratamiento y durante al menos 6 meses despu\u00e9s de la \u00faltima dosis de cada ciclo de tratamiento.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Si usted es un hombre con una pareja femenina que puede quedar embarazada, utilice un m\u00e9todo anticonceptivo eficaz durante el tratamiento y durante al menos 14 semanas despu\u00e9s de la \u00faltima dosis de cada ciclo de tratamiento.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-c53937ffc9012358802316a07113fac6\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Before_Taking_Cladribine_Mavenclad_Tablets\"><\/span>Antes de tomar comprimidos de cladribina (Mavenclad)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">No tome este medicamento si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tener c\u00e1ncer\u00a0<\/li>\n\n\n\n<li>Tengo VIH, <a href=\"https:\/\/www.cdc.gov\/tb\/about\/index.html\">tuberculosis<\/a> Tuberculosis (TB), hepatitis o cualquier otra infecci\u00f3n activa<\/li>\n\n\n\n<li>Son al\u00e9rgicos a la cladribina o a cualquier otro componente del producto.<\/li>\n\n\n\n<li>\u00bfEst\u00e1s amamantando o embarazada?<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Antes de recibir su primera dosis de cladribina, informe a su m\u00e9dico si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sospecho que tienes una infecci\u00f3n.<\/li>\n\n\n\n<li>Tener problemas card\u00edacos, hep\u00e1ticos o renales<\/li>\n\n\n\n<li>Tener c\u00e1ncer o haberlo tenido en el pasado<\/li>\n\n\n\n<li>Ha usado, usa actualmente o planea usar medicamentos que afectan el sistema inmunol\u00f3gico o las c\u00e9lulas sangu\u00edneas.<\/li>\n\n\n\n<li>Ha usado, usa actualmente o planea usar otros medicamentos para la esclerosis m\u00faltiple.<\/li>\n\n\n\n<li>Han sido vacunados recientemente o tienen programada su vacunaci\u00f3n (generalmente no se recomienda la vacunaci\u00f3n con vacunas vivas o atenuadas entre 4 y 6 semanas antes, durante o despu\u00e9s del tratamiento con cladribina).<\/li>\n\n\n\n<li>\u00bfEst\u00e1 embarazada o planea quedar embarazada?<\/li>\n\n\n\n<li>Si est\u00e1 amamantando o planea amamantar (evite amamantar durante el tratamiento y durante los 10 d\u00edas posteriores a la \u00faltima dosis del ciclo).<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cladribine_Mavenclad_Dosing\"><\/span>Dosificaci\u00f3n de cladribina (Mavenclad)&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Su m\u00e9dico determinar\u00e1 la dosis seg\u00fan su peso corporal. Mavenclad se administra en dos ciclos de tratamiento anuales. La dosis total recomendada es de 1,75 mg\/kg por ciclo. Cada ciclo se divide en dos fases de tratamiento.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"First_treatment_course_year_1\"><\/span>Primer ciclo de tratamiento (a\u00f1o 1)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ciclo de tratamiento 1<\/strong>: Tome la dosis recomendada una vez al d\u00eda durante 4 a 5 d\u00edas consecutivos.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ciclo de tratamiento 2<\/strong>: Repita la dosis entre 23 y 27 d\u00edas despu\u00e9s.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Second_treatment_course_year_2\"><\/span>Segundo ciclo de tratamiento (a\u00f1o 2)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ciclo de tratamiento 1<\/strong>: Tome la dosis recomendada una vez al d\u00eda durante 4 a 5 d\u00edas seguidos, al menos 43 semanas despu\u00e9s de la \u00faltima dosis del ciclo 2 del primer tratamiento.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ciclo de tratamiento 2:<\/strong> Repita la dosis entre 23 y 27 d\u00edas despu\u00e9s.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Proper_Use\"><\/span>Uso adecuado<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tome Mavenclad exactamente como se lo recet\u00f3 su m\u00e9dico. No tome m\u00e1s de dos comprimidos al d\u00eda.\u00a0<\/li>\n\n\n\n<li>Ingi\u00e9rase la tableta entera inmediatamente despu\u00e9s de abrir el envase.<\/li>\n\n\n\n<li>Evite triturar, masticar o partir las tabletas.<\/li>\n\n\n\n<li>Puede tomar este medicamento con o sin alimentos.\u00a0<\/li>\n\n\n\n<li>Complete cada ciclo de tratamiento exactamente como se le indic\u00f3 y hable con su m\u00e9dico antes de realizar cualquier cambio en su plan de tratamiento.\u00a0<\/li>\n\n\n\n<li>Mantenga las manos secas mientras manipula las tabletas. Inmediatamente despu\u00e9s de tomar una tableta, l\u00e1vese bien las manos.\u00a0<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Minimice el contacto directo entre la tableta y su piel. No toque su nariz, ojos ni otras partes del cuerpo.\u00a0<\/li>\n\n\n\n<li>Si la tableta entra en contacto con una superficie, lave la superficie inmediatamente con agua.<\/li>\n\n\n\n<li>T\u00f3mese la dosis con al menos 3 horas de diferencia de otros medicamentos orales.<\/li>\n\n\n\n<li>Si olvida una dosis, t\u00f3mela inmediatamente despu\u00e9s de recordarlo, el mismo d\u00eda. Si ya pas\u00f3 el d\u00eda, t\u00f3mela al d\u00eda siguiente. Nunca tome dos dosis al mismo tiempo.\u00a0<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Monitoring_During_Treatment\"><\/span>Monitorizaci\u00f3n durante el tratamiento<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Su m\u00e9dico le realizar\u00e1 un seguimiento antes y durante el tratamiento para garantizar la seguridad y eficacia de Mavenclad. Esto puede incluir an\u00e1lisis de sangre para comprobar el recuento de linfocitos (gl\u00f3bulos blancos), la funci\u00f3n hep\u00e1tica y la funci\u00f3n renal. Tambi\u00e9n se le realizar\u00e1n pruebas de detecci\u00f3n de infecciones como tuberculosis, hepatitis y VIH antes de comenzar el tratamiento. Las mujeres en edad f\u00e9rtil deber\u00e1n realizarse una prueba de embarazo antes de cada ciclo de tratamiento.<\/p>\n\n\n\n<div  id=\"call-to-action-5a2f7d04739026179b99b6e7500f54e5\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cladribine_Mavenclad_Side_Effects\"><\/span>Efectos secundarios de la cladribina (Mavenclad)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Common_Side_Effects\"><\/span>Efectos secundarios comunes<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-side-effects.jpg\" alt=\"Paciente con EM tose como efecto secundario al tomar cladribina \" class=\"wp-image-29090\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-side-effects.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-side-effects-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-side-effects-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-side-effects-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-side-effects-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-side-effects-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-side-effects-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-side-effects-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<ul class=\"wp-block-list\">\n<li>Infecci\u00f3n de las v\u00edas respiratorias superiores<\/li>\n\n\n\n<li>Recuento bajo de gl\u00f3bulos blancos<\/li>\n\n\n\n<li>Dolor de cabeza<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Consulte con su m\u00e9dico o farmac\u00e9utico si alg\u00fan efecto secundario empeora o persiste.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Severe_Side_Effects\"><\/span>Efectos secundarios graves<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Llame a su proveedor de atenci\u00f3n m\u00e9dica de inmediato o busque atenci\u00f3n de emergencia si presenta alguno de los siguientes s\u00edntomas:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fiebre, dolor de garganta, escalofr\u00edos, dolor muscular, tos u otros signos de infecci\u00f3n.<\/li>\n\n\n\n<li>Tos, dolor de pecho, expectoraci\u00f3n de sangre o mucosidad, cansancio, p\u00e9rdida de peso, p\u00e9rdida de apetito, escalofr\u00edos, fiebre, sudores nocturnos<\/li>\n\n\n\n<li>Erupci\u00f3n dolorosa con ampollas<\/li>\n\n\n\n<li>Ardor, hormigueo, entumecimiento o picaz\u00f3n en la piel.<\/li>\n\n\n\n<li>Erupci\u00f3n cut\u00e1nea, dificultad para respirar o tragar, hinchaz\u00f3n de la cara, los labios, la lengua o la garganta.<\/li>\n\n\n\n<li>Escalofr\u00edos, fiebre, n\u00e1useas, v\u00f3mitos, dolor en la espalda, el costado o la ingle, micci\u00f3n frecuente y dolorosa.<\/li>\n\n\n\n<li>Sangrado o hematomas inusuales<\/li>\n\n\n\n<li>Debilidad en un lado del cuerpo, p\u00e9rdida de coordinaci\u00f3n en brazos o piernas, disminuci\u00f3n de la fuerza, problemas de equilibrio, confusi\u00f3n, cambios en la visi\u00f3n, el pensamiento, la memoria o la personalidad.<\/li>\n\n\n\n<li>Dificultad para respirar, taquicardia, dolor de cabeza, mareos, palidez, confusi\u00f3n, cansancio.<\/li>\n\n\n\n<li>N\u00e1useas, v\u00f3mitos, cansancio extremo, p\u00e9rdida del apetito, dolor en la parte superior derecha del est\u00f3mago, coloraci\u00f3n amarillenta de la piel o los ojos, orina oscura.<\/li>\n\n\n\n<li>Dificultad para respirar, latidos card\u00edacos r\u00e1pidos o irregulares, hinchaz\u00f3n en alguna parte del cuerpo.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cladribine_Mavenclad_Cost\"><\/span>Costo de la cladribina (Mavenclad)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">El costo puede variar seg\u00fan su plan de seguro, ubicaci\u00f3n y farmacia. Consulte con su aseguradora si su plan cubre este medicamento o si requiere autorizaci\u00f3n previa.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Muchos planes de seguro, incluidos Medicare Part D y los planes de seguro comerciales, cubren Mavenclad, aunque a menudo se requiere autorizaci\u00f3n previa. Dependiendo de su cobertura, es posible que a\u00fan deba pagar copagos o coseguro. Su m\u00e9dico o farmacia especializada puede ayudarle a verificar sus beneficios y calcular sus gastos de bolsillo antes de que comience el tratamiento.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">EMD Serono, Inc., una filial de Merck, proporciona apoyo financiero y terap\u00e9utico a los pacientes a trav\u00e9s de su servicio de asistencia MS LifeLines.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Si usted es elegible y tiene un seguro comercial, puede calificar para el Programa de Asistencia para Copagos de MS LifeLines. Para obtener m\u00e1s informaci\u00f3n, <a href=\"https:\/\/ameripharmaspecialty.com\/es\/asistencia-financiera\/\">Cont\u00e1ctanos<\/a> si est\u00e1 interesado en asistencia financiera o <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ayuda-para-el-copago-de-cladribina\/\">Asistencia para el copago de cladribina<\/a>.<\/p>\n\n\n\n<div  id=\"call-to-action-4ccbd7ae0753693f6fab16137137e365\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u00bfCalifica usted para el copago $0?\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tHable con un especialista para averiguarlo\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Cont\u00e1ctenos<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusi\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Mavenclad es una opci\u00f3n de tratamiento oral eficaz para ciertos adultos con formas recurrentes de esclerosis m\u00faltiple. Aunque solo se administra durante dos ciclos de tratamiento anuales, es necesario un seguimiento cuidadoso debido a sus posibles riesgos, como infecciones, c\u00e1ncer y da\u00f1o fetal. Si est\u00e1 considerando Mavenclad, consulte con su m\u00e9dico para determinar si los beneficios superan los riesgos en su caso particular.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>La cladribina (nombre comercial: Mavenclad) es un medicamento oral de venta con receta que se utiliza para tratar a adultos con formas recurrentes de esclerosis m\u00faltiple (EM). A diferencia de muchos medicamentos para la EM que requieren tratamiento continuo, Mavenclad se administra en dos ciclos de tratamiento anuales dise\u00f1ados para proporcionar un control duradero de la enfermedad.<\/p>","protected":false},"author":7,"featured_media":29089,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[26],"tags":[8],"class_list":["post-29087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.4 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cladribine (Mavenclad): Uses, How It Works, and Side Effects - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about Cladribine (Mavenclad) for relapsing MS, including how it works, dosing, effectiveness, side effects, warnings, monitoring, and cost.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/esclerosis-multiple\/cladribine-mavenclad-usos-funcionamiento-y-efectos-secundarios\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cladribine (Mavenclad): Uses, How It Works, and Side Effects\" \/>\n<meta property=\"og:description\" content=\"Learn about Cladribine (Mavenclad) for relapsing MS, including how it works, dosing, effectiveness, side effects, warnings, monitoring, and cost.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/esclerosis-multiple\/cladribine-mavenclad-usos-funcionamiento-y-efectos-secundarios\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-11T21:06:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-11T21:06:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"Cladribine (Mavenclad): Uses, How It Works, and Side Effects\",\"datePublished\":\"2026-08-11T21:06:18+00:00\",\"dateModified\":\"2026-08-11T21:06:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/\"},\"wordCount\":1514,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/cladribine-patient.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"Multiple Sclerosis\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/\",\"name\":\"Cladribine (Mavenclad): Uses, How It Works, and Side Effects - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/cladribine-patient.jpg\",\"datePublished\":\"2026-08-11T21:06:18+00:00\",\"dateModified\":\"2026-08-11T21:06:21+00:00\",\"description\":\"Learn about Cladribine (Mavenclad) for relapsing MS, including how it works, dosing, effectiveness, side effects, warnings, monitoring, and cost.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/cladribine-patient.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/cladribine-patient.jpg\",\"width\":1280,\"height\":853,\"caption\":\"MS patient who takes cladribine in a wheelchair talking to a friend\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/multiple-sclerosis\\\/cladribine-mavenclad-uses-how-it-works-and-side-effects\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cladribine (Mavenclad): Uses, How It Works, and Side Effects\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cladribina (Mavenclad): Usos, funcionamiento y efectos secundarios - AmeriPharma\u00ae Specialty Care","description":"Inf\u00f3rmese sobre la cladribina (Mavenclad) para la esclerosis m\u00faltiple remitente-recurrente, incluyendo c\u00f3mo funciona, la dosis, la eficacia, los efectos secundarios, las advertencias, el seguimiento y el coste.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/esclerosis-multiple\/cladribine-mavenclad-usos-funcionamiento-y-efectos-secundarios\/","og_locale":"es_MX","og_type":"article","og_title":"Cladribine (Mavenclad): Uses, How It Works, and Side Effects","og_description":"Learn about Cladribine (Mavenclad) for relapsing MS, including how it works, dosing, effectiveness, side effects, warnings, monitoring, and cost.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/esclerosis-multiple\/cladribine-mavenclad-usos-funcionamiento-y-efectos-secundarios\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2026-08-11T21:06:18+00:00","article_modified_time":"2026-08-11T21:06:21+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"Cladribine (Mavenclad): Uses, How It Works, and Side Effects","datePublished":"2026-08-11T21:06:18+00:00","dateModified":"2026-08-11T21:06:21+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/"},"wordCount":1514,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["Multiple Sclerosis"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/","url":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/","name":"Cladribina (Mavenclad): Usos, funcionamiento y efectos secundarios - AmeriPharma\u00ae Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg","datePublished":"2026-08-11T21:06:18+00:00","dateModified":"2026-08-11T21:06:21+00:00","description":"Inf\u00f3rmese sobre la cladribina (Mavenclad) para la esclerosis m\u00faltiple remitente-recurrente, incluyendo c\u00f3mo funciona, la dosis, la eficacia, los efectos secundarios, las advertencias, el seguimiento y el coste.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg","width":1280,"height":853,"caption":"MS patient who takes cladribine in a wheelchair talking to a friend"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/multiple-sclerosis\/cladribine-mavenclad-uses-how-it-works-and-side-effects\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Cladribine (Mavenclad): Uses, How It Works, and Side Effects"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Cladribine (brand name: Mavenclad) is an oral prescription medication used to treat adults with relapsing forms of multiple sclerosis (MS). Unlike many MS medications that require continuous treatment, Mavenclad is taken in two yearly treatment courses designed to provide long-lasting disease control.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/08\/cladribine-patient.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/multiple-sclerosis\/\" rel=\"category tag\">Multiple Sclerosis<\/a>","rttpg_excerpt":"Cladribine (brand name: Mavenclad) is an oral prescription medication used to treat adults with relapsing forms of multiple sclerosis (MS). Unlike many MS medications that require continuous treatment, Mavenclad is taken in two yearly treatment courses designed to provide long-lasting disease control.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/29087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=29087"}],"version-history":[{"count":4,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/29087\/revisions"}],"predecessor-version":[{"id":29094,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/29087\/revisions\/29094"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/29089"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=29087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=29087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=29087"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}